With Brexit fast approaching and the recent launch of the UK Life Science Strategy & Sector Deal, strong collaboration between Industry and the NHS will be essential to maintain the UK's overall commercial attractiveness - but will a structured collaboration model become a reality in 2018 or will it remain a pipe dream?
The 4th Annual UK Market Access Summit will give Industry and NHS colleagues an opportunity to discuss existing initiatives, plans for collaboration, and learnings from successful engagements that will positively impact timely access to medicines for patients in the UK.
Held over several sessions including presentations, panel discussion, debate and networking breaks, this year's summit will provide exclusive insights from:
- Peter Huskinson, National Commercial Director of Specialised Commissioning, NHS England
- Andrew White, Medicines Optimisation Lead, Greater Manchester Health and Social Care Partnership
- Robert Duncombe, Director of Pharmacy, The Christie NHS Foundation Trust
- Jayne Spink, Chief Executive, Genetic Alliance